E-DRUG: HAI supports no Long-Acting Analogue Insulins on WHO Essential Medicines List
-----------------------------------------------------------------------------------------------------------
HAI Commends WHO Decision Not To Include Long-Acting Analogue Insulins On The Essential Medicines List
Dear e-Druggers,
Health Action International today issued a press release commending the
decision by the World Health Organization (WHO) to reject a proposal to include long-acting
analogue insulin on the WHO Model List of Essential Medicines (EML).
A decision to include long-acting analogue insulin on the EML would have
increased pressure on national governments to purchase these insulins,
which are seven to nine times more expensive than human insulin, while
providing limited added value to users. The result would have been fewer
people being treated and more deaths.
To read the full press release, including comments from Health Action
International¹s Dr Margaret Ewen, co-lead of the Addressing the Challenge
and Constraints of Insulin Sources and Supply (ACCISS) Study, please go to:
http://haiweb.org/media-centre/
Kind regards,
James Still
Communications Advisor
Health Action International
e: james@haiweb.org